summit trial tirzepatide and Cardiovascular Outcomes: A Narrative Review of Mechanisms, Efficacy and Implications for Heart Failure Management - Abdul‐Hafez - 2026 - Endocrinology, Diabetes & Metabolism Has Tirzepatide Scaled the HFpEF/Obesity

According to the CDC, as of 2021, 38.1 million adults (14.7%) in the United States had diabetes, with the incidence increasing with age

Following subcutaneous injection in human studies: Bioavailability approaches 100% with subcutaneous administration Time to maximum plasma concentration (Tmax) occurs at approximately 1.0 hour (range 0.5-1.0 hours) Maximum plasma concentration (Cmax) averages 72.8 ng/mL Area under the curve (AUC) measures 276 hrng/mL The peptide exhibits relatively low plasma protein binding at 21% , allowing substantial free drug availability for central nervous system penetration

Don't increase your dose if side effects haven't cleared up, as this often makes them worse and harder to tolerate

Egg Salad with Seed Crackers Hard-boiled eggs can get repurposed for lunch